Steps towards a malaria vaccine.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Research in Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0923-2494(91)90139-APMID 1817288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species.

  1991cited by this paper
• Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody.

  1990cited by this paper
• Structural diversity of Plasmodium falciparum gp200 is detected by T cells

  1990cited by this paper
• Major population differences in T cell response to a malaria sporozoite vaccine candidate.

  1990cited by this paper
• The generation of genetic diversity in malaria parasites.

  1990cited by this paper
• [Vaccination against malaria: initial trial with an ant-sporozoite vaccine, (NANP)3-TT (RO 40-2361) in Africa (Bobo-Dioulasso, Burkina Faso)].

  1990cited by this paper
• Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens.

  1990cited by this paper
• Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

  1990cited by this paper
• Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins.

  1990cited by this paper
• Renal pathology in owl monkeys in Plasmodium falciparum vaccine trials.

  1990cited by this paper
• Characterization of regulatory T cell responses to defined immunodominant T cell epitopes of the Plasmodium falciparum antigen Pf155/RESA.

  1990cited by this paper
• The role of CD4+ T cells in the protective immune response to Plasmodium chabaudi in vivo.

  1990cited by this paper
• Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines.

  1990cited by this paper
• Novel cross‐reactive epitopes on asexual blood stage antigens of Plasmodium falciparum

  1990cited by this paper
• The T cell reactivity against the major merozoite protein of Plasmodium falciparum.

  1990cited by this paper
• Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion

  1990cited by this paper
• Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.

  1990cited by this paper
• Vaccination contre le paludisme: premier essai avec un vaccin antisporozoïte, le (NANP)3-TT (RO 40-2361) en Afrique (Bobo-Dioulasso, Burkina Faso).

  1990cited by this paper
• How much malaria is there worldwide

  1989cited by this paper
• An update on candidate malaria vaccines

  1989cited by this paper
• Application of exoantigens of Babesia and Plasmodium in vaccine development.

  1989cited by this paper
• Expression of the RESA gene in Plasmodium falciparum isolate FCR3 is prevented by a subtelomeric deletion

  1989cited by this paper
• Future potential of malaria vaccines.

  1989cited by this paper
• Pre-erythrocytic stage malaria vaccine development: current status and future prospects.

  1989cited by this paper
• Estimate of anti-Plasmodium falciparum sporozoite activity in humans vaccinated with synthetic circumsporozoite protein (NANP)3.

  1989cited by this paper
• Cloned T cells provide help for malaria‐specific polyclonal antibody responses

  1989cited by this paper
• Rationale for the development of an engineered sporozoite malaria vaccine.

  1989cited by this paper
• Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein.

  1989cited by this paper
• Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes.

  1989cited by this paper
• Development of sporozoite vaccines for malaria.

  1989cited by this paper
• How much malaria is there worldwide?

  1989cited by this paper
• Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia.

  1989cited by this paper
• Small area variation in prevalence of an S-antigen serotype of Plasmodium falciparum in villages of Madang, Papua New Guinea.

  1989cited by this paper
• A 46,000 dalton Plasmodium falciparum merozoite surface glycoprotein not related to the 185,000-195,000 dalton schizont precursor molecule: isolation and characterization.

  1988cited by this paper
• A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules

  1988cited by this paper
• A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria

  1988cited by this paper
• Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule.

  1988cited by this paper
• Permethrin-treated bed nets (mosquito nets) prevent malaria in Gambian children.

  1988cited by this paper
• Pre‐erythrocytic stages of plasmodia. Role of specific and nonspecific factors

  1988cited by this paper
• Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans).

  1988cited by this paper
• Plasmodium vivax: cloning and expression of a major blood-stage surface antigen.

  1988cited by this paper
• Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria.

  1988cited by this paper
• Expression and function of erythrocyte‐associated surface antigens in malaria

  1988cited by this paper
• A hybrid gene to express protein epitopes from both sporozoite and merozoite surface antigens of Plasmodium falciparum

  1988cited by this paper
• Aldolase activity of a Plasmodium falciparum protein with protective properties.

  1988cited by this paper
• Anti-sporozoite antibodies and immunity to malaria in a rural Gambian population.

  1988cited by this paper
• Protein p126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites

  1988cited by this paper
• The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development.

  1988cited by this paper
• Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2.

  1988cited by this paper
• Hepatitis B Surface Antigen as Carrier Matrix for the Repetitive Epitope of the Circumsporozoite Protein of Plasmodium Falciparum.

  1988cited by this paper
• The precursor to major merozoite surface antigens: structure and role in immunity.

  1988cited by this paper
• Field trial of rhesus rotavirus vaccine in infants.

  1988cited by this paper
• Immunity to sexual stages of malaria parasites.

  1988cited by this paper
• Antigenic variation and antigenic diversity in malaria.

  1987cited by this paper
• Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.

  1987cited by this paper
• Vaccination-induced variation in the 140 kD merozoite surface antigen of Plasmodium knowlesi malaria

  1987cited by this paper
• Induction of protective immunity against experimental infection with malaria using synthetic peptides

  1987cited by this paper
• Antigenic variation and antigenic diversity in malaria.

  1987cited by this paper
• Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

  1987cited by this paper
• Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine

  1987cited by this paper
• Detection of Plasmodium falciparum DNA using repetitive DNA clones as species specific probes.

  1987cited by this paper
• Antibodies to Pf155, a major antigen of Plasmodium falciparum: longitudinal studies in humans.

  1987cited by this paper
• Genetic analysis of the human malaria parasite Plasmodium falciparum.

  1987cited by this paper
• Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.

  1987cited by this paper
• Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

  1987cited by this paper
• The ISCOM: an immunostimulating complex.

  1987cited by this paper
• Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro.

  1986cited by this paper
• Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen.

  1986cited by this paper
• Antigenic repeat structures in proteins of Plasmodium falciparum.

  1986cited by this paper
• Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion.

  1986cited by this paper
• Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity.

  1986cited by this paper
• Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.

  1986cited by this paper
• Malaria transmission and develoment of anti-sporozoite antibodies in a rural african community

  1986cited by this paper
• The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.

  1986cited by this paper
• Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys.

  1985cited by this paper
• Role of T cells in preventing transmission of rodent malaria.

  1985cited by this paper
• Immunization of monkeys with a 140 kilodalton merozoite surface protein of Plasmodium knowlesi malaria: appearance of alternate forms of this protein.

  1985cited by this paper
• Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum

  1985cited by this paper
• Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria.

  1985cited by this paper
• Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope.

  1985cited by this paper
• In vitro inhibition of intracellular growth of Plasmodium falciparum by immune sera.

  1984cited by this paper
• In vitro and in vivo studies on protective and inhibitory antibodies against Plasmodium falciparum in the Saimiri monkey.

  1984cited by this paper
• Immune sera recognize on erythrocytes a Plasmodium falciparum antigen composed of repeated amino acid sequences

  1984cited by this paper
• Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.

  1984cited by this paper
• Maternal inhibition of malaria vaccination in mice can be overcome by giving a second dose of vaccine.

  1984cited by this paper
• Protective immunization of the squirrel monkey against asexual blood stages of Plasmodium falciparum by use of parasite protein fractions.

  1984cited by this paper
• Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages

  1984cited by this paper
• Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies.

  1984cited by this paper
• An automated large-scale culture system of Plasmodium falciparum using tangential flow filtration for medium change

  1983cited by this paper
• Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen

  1983cited by this paper
• Expression of strain‐specific surface antigens on Plasmodium falciparum‐infected erythrocytes

  1982cited by this paper
• Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies

  1981cited by this paper
• Immune responses in malaria

  1981cited by this paper
• The Isolation of Malaria Parasites and Their Constituents**This chapter is a revised version of a review by J. P. Kreier published in 1977 in the Bulletin of the World Health Organization 55, 317–331.

  1980cited by this paper
• Immunization against Sporozoites

  1980cited by this paper
• The orientation of immunological research in relation to the global antimalaria programme.

  1979cited by this paper
• Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria.

  1979cited by this paper
• The orientation of immunological research in relation to the global antimalaria programme.

  1979cited by this paper
• Antibody mediated mechanisms of immunity to malaria induced by vaccination with Plasmodium knowlesi merozoites.

  1978cited by this paper
• Histidine-rich protein as a model malaria vaccine.

  1978cited by this paper

• Impact of Plasmodium Falciparum Malaria Infection on Red Blood Cell Indices in Adults Living in Ido-Ekiti, South-West Nigeria

  2015cites this paper
• Effect of Anti-malaria Drugs on Some Blood Cell Lines Parameters in Adult Individuals Infected with Acute Uncomplicated Plasmodium falciparum Malaria

  2014cites this paper
• Effect of Anti-malaria Drugs on Some Blood Cell Lines Parameters in Adult Individuals Infected with Acute Uncomplicated Plasmodium falciparum Malaria

  2014cites this paper
• Estimation of Stress Induces By Malaria Parasite Infection and Effect of Anti-malaria Drugs on Stress Index, Lipid Profile in Uncomplicated Acute Malaria Infected Adult Individuals

  2014cites this paper
• Effect of blood group and demographic characteristics on malaria infection, oxidative stress and haemoglobin levels in south western Nigeria.

  2010cites this paper
• Role of heat-labile serum factor or host complement in the inhibition of Plasmodium falciparum sporogonic stages in Anopheles stephensi by gametocyte carriers' serological factors

  2007cites this paper
• Malaria vaccines.

  1999cites this paper
• Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.

  1996cites this paper
• The biology of malarial parasite in the mosquito--a review.

  1996cites this paper
• Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfs16 protein produced in yeast.

  1995cites this paper
• Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.

  1994cites this paper
• Cytokines and T-cell response in malaria.

  1994cites this paper
• Malaria vaccines.

  1992cites this paper